Our leases mainly include our worldwide office and research and development facilities which are all classified as operating leases. Certain leases include renewal options that are under our discretion. The leases expire at various dates through fiscal year 2029, some of which include options to extend the lease for up to 5 years. For the nine months ended March 27, 2021, we recorded approximately $7.5 million of operating leases expense. Our short-term leases are immaterial and we do not have finance leases.

As of March 27, 2021, the components of leases and lease costs are as follows (in millions):

	March		June
	2021		2020
Operating lease right-of-use assets	$	35.1	$	21.0
Operating lease liabilities	$	9.7	$	6.5
Operating lease liabilities, long-term		26.9		14.6
Total operating lease liabilities	$	36.6	$	21.1

Supplemental cash flow information related to leases is as follows (in millions):

	Nine Months Ended
	March
	2021		2020
Cash paid for operating leases included in operating cash flows	$	7.3	$	7.1
Supplemental non-cash information related to lease liabilities arising from obtaining right-of-use assets		21.7	2.8

As of March 27, 2021, the weighted average remaining lease term is 6.2 years, and the weighted average discount rate is 4.0%.

Future minimum lease payments for the operating lease liabilities are as follows (in millions):

	Operating
	Lease
Fiscal Year	Payments
Remainder of 2021	$	2.7
2022		10.1
2023		6.3
2024		4.8
2025		4.0
Thereafter		13.4
Total future minimum operating lease payments		41.3
Less: interest		(4.7	)
Total lease liabilities	$	36.6